No Data
TIANJIN DEV (00882.HK): Xia Binhui has been appointed as Executive Director and Deputy General Manager.
Gelonghui reported on December 30 that TIANJIN DEV (00882.HK) announced that the Board of Directors has appointed Xia Binhui as the company's executive director and deputy general manager, effective from December 30, 2024.
TIANJIN DEV (00882): Xia Binhui has been appointed as Executive Director.
TIANJIN DEV (00882) announced that Xia Binhui has been appointed as the company's executive Director and vice general manager, starting from 2024...
Express News | Tianjin Development Holdings Ltd - Xia Binhui Appointed as Executive Director
Tianjin Development Subsidiary to Repurchase Shares, Grant Shares Under Share Award Scheme
Tianjin DEV (00882.HK) subsidiary Tianjin Lisheng Pharmaceutical plans to repurchase shares and adopt a stock incentive plan.
On December 20, Grizzly Holdings announced that TIANJIN DEV (00882.HK) has approved a share buyback plan at the Board of Directors of Tianjin Lisheng Pharmaceutical (a non-wholly-owned subsidiary indirectly listed on the Shenzhen Stock Exchange) on December 20, 2024. Accordingly, starting from December 21, 2024, within a period of twelve months, Tianjin Lisheng Pharmaceutical is allowed to repurchase its ordinary shares through centralized bidding on the Shenzhen Stock Exchange at the current market price, with a total amount not less than 76.5 million yuan and not exceeding 0.153 billion yuan. The Board of Directors of Tianjin Lisheng Pharmaceutical recommends that this be approved by its Shareholders at the Shareholders' meeting.
Express News | Tianjin Development - Unit to Conduct Repurchase of Ordinary Shares for Not Less Than RMB76.5 Mln and up to RMB153 Mln
No Data
